P Speiser

4.2k total citations
163 papers, 3.0k citations indexed

About

P Speiser is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, P Speiser has authored 163 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 38 papers in Molecular Biology and 33 papers in Cancer Research. Recurrent topics in P Speiser's work include Ovarian cancer diagnosis and treatment (29 papers), Cancer Genomics and Diagnostics (21 papers) and Blood groups and transfusion (19 papers). P Speiser is often cited by papers focused on Ovarian cancer diagnosis and treatment (29 papers), Cancer Genomics and Diagnostics (21 papers) and Blood groups and transfusion (19 papers). P Speiser collaborates with scholars based in Austria, Germany and Belgium. P Speiser's co-authors include Robert Zeillinger, Charles Theillet, Christian Schneeberger, Frank Courjal, Alexander Reinthaller, Andreas Obermair, Sepp Leodolter, Jalid Sehouli, Dan Cacsire Castillo‐Tong and Alexandra Kaider and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

P Speiser

153 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Speiser Austria 31 1.3k 925 777 602 440 163 3.0k
Julie A. DeLoia United States 30 1.2k 1.0× 812 0.9× 428 0.6× 698 1.2× 553 1.3× 63 2.9k
Ana‐Maria Bamberger Germany 39 1.3k 1.0× 889 1.0× 379 0.5× 552 0.9× 745 1.7× 87 3.9k
Shiro Nozawa Japan 31 1.5k 1.2× 774 0.8× 275 0.4× 678 1.1× 610 1.4× 151 3.5k
Ate G.J. van der Zee Netherlands 35 1.5k 1.2× 1.0k 1.1× 738 0.9× 943 1.6× 344 0.8× 63 3.8k
Masaki Inoue Japan 33 1.1k 0.9× 768 0.8× 368 0.5× 241 0.4× 244 0.6× 93 3.2k
Cécile Le Page Canada 28 1.2k 1.0× 1.1k 1.2× 567 0.7× 355 0.6× 174 0.4× 62 3.1k
Hugo Arias‐Pulido United States 30 1.6k 1.2× 778 0.8× 637 0.8× 167 0.3× 435 1.0× 59 2.9k
Karin Sundfeldt Sweden 30 1.3k 1.0× 521 0.6× 606 0.8× 927 1.5× 226 0.5× 91 2.7k
Sílvia Regina Rogatto Brazil 34 1.9k 1.5× 719 0.8× 915 1.2× 190 0.3× 403 0.9× 195 3.4k
August Vidal Spain 38 3.1k 2.4× 856 0.9× 1.7k 2.2× 515 0.9× 257 0.6× 110 5.2k

Countries citing papers authored by P Speiser

Since Specialization
Citations

This map shows the geographic impact of P Speiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Speiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Speiser more than expected).

Fields of papers citing papers by P Speiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Speiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Speiser. The network helps show where P Speiser may publish in the future.

Co-authorship network of co-authors of P Speiser

This figure shows the co-authorship network connecting the top 25 collaborators of P Speiser. A scholar is included among the top collaborators of P Speiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Speiser. P Speiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kohrn, Brendan F., Jeanne Fredrickson, Marc R. Radke, et al.. (2022). Uterine Lavage Identifies Cancer Mutations and Increased TP53 Somatic Mutation Burden in Individuals with Ovarian Cancer. Cancer Research Communications. 2(10). 1282–1292. 9 indexed citations
2.
Bagnoli, Marina, Tingyan Shi, Charlie Gourley, et al.. (2019). Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions. Cells. 8(3). 200–200. 6 indexed citations
3.
Natter, C, Stephan Polterauer, Dan Cacsire Castillo‐Tong, et al.. (2013). Association of TAP Gene Polymorphisms and Risk of Cervical Intraepithelial Neoplasia. Disease Markers. 35(2). 79–84. 20 indexed citations
4.
Grimm, Christoph, Sepp Leodolter, Cle mens Tempfer, et al.. (2005). A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer. Gynecologic Oncology. 100(3). 506–510. 27 indexed citations
5.
Schernhammer, Eva, et al.. (2005). Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer. British Journal of Cancer. 92(6). 1019–1025. 10 indexed citations
6.
Speiser, P, Frédéric Kridelka, Cle mens Tempfer, et al.. (1999). CD44v6 expression is an independent prognostic factor in node-negative FIGO stage IB cervical carcinoma. International Journal of Gynecological Cancer. 9(2). 160–165. 8 indexed citations
7.
Obermair, Andreas, C. Wanner, P Speiser, et al.. (1998). Prognostic impact of microvessel density in stage IB carcinoma of the uterine cervix. Annals of Oncology. 9. 78–78. 1 indexed citations
8.
Courjal, Frank, Marguerite Cuny, Joëlle Simony-Lafontaine, et al.. (1997). Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.. PubMed. 57(19). 4360–7. 195 indexed citations
9.
Courjal, Frank, Marguerite Cuny, Carmen Rodrı́guez, et al.. (1996). DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Breast Cancer Research and Treatment. 74(12). 1 indexed citations
10.
Courjal, Frank, et al.. (1996). Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection ofcyclin D1 in breast andcyclin E in ovarian tumors. International Journal of Cancer. 69(4). 247–253. 160 indexed citations
11.
Nagele, Fritz, et al.. (1996). CA 125 als Prognosefaktor für das Überleben bei Patientinnen mit epithelialen Ovarialkarzinomen des FIGO-Stadium I - preliminäre Ergebnisse. Geburtshilfe und Frauenheilkunde. 56(2). 79–82. 4 indexed citations
12.
Schneeberger, Christian, Susanne Eder, P Speiser, & Robert Zeillinger. (1996). Competitive reverse transcriptase-PCR: an improved method for determination of c-erbB-2 gene expression.. PubMed. 16(2). 849–52. 4 indexed citations
13.
Strohmer, Heinz, et al.. (1995). Ovarian function during low-dose oral contraceptive use. Contraception. 51(6). 329–333. 29 indexed citations
14.
Wegmann, T, Ulrich H. Frey, & P Speiser. (1979). [Mycotic panuveitis (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 68(10). 323–5. 1 indexed citations
15.
Speiser, P, et al.. (1964). [OBSERVATIONS ON INCREASED INCIDENCE OF ANTI-GMA IN CHILDREN UP TO 2 YEARS OF AGE WITH STUDIES ON ANTIGEN AFFINITY BETWEEN GM(A) AND GM(X) WITH SMALLPOX-, BCG- AND POLIOMYELITIS ANTIGENS].. PubMed. 10. 425–31. 3 indexed citations
16.
Speiser, P. (1958). Frequenz und Bedeutung seltener Rhesusmerkmale (C und E bei Rhesus-Negativen, Du und Cw). Annals of Hematology. 4(1). 1–7. 5 indexed citations
19.
Kölbl, H & P Speiser. (1953). [Icterus praecox et prolongatus caused by anti-P antibodies].. PubMed. 8(4). 367–70. 1 indexed citations
20.
Braunsteiner, H, et al.. (1951). [Severe hemolytic anemia with blockage of incomplete antibodies].. PubMed. 32(4). 157–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026